People v. Cancer
In the 2021 People v. Cancer summit, The Atlantic explored the latest science and the important ways in which prevention, diagnosis, treatment, and well-being are interrelated. Even in the midst of a global pandemic, progress continues to be made toward not only treating cancer and extending lives, but creating a more robust, holistic ecosystem of care.
We brought together medical providers, scientists, survivors, and patients for in-depth conversations about a disease that remains one of the world’s most complex, and most lethal. At People v. Cancer, The Atlantic explored the most crucial questions of the day: What is the future of cancer care? What can be done to improve lives for all—along the entire spectrum of care?
Speakers
Hesham Abdullah
Senior Vice President and Head of Oncology Clinical Development, GSK
Underwriter Session
Jeff Allen
CEO and President, Friends of Cancer Research
Underwriter Session
Vinod Balachandran
Surgeon-Scientist, Memorial Sloan Kettering Cancer Center
Wendy Short Bartie
Senior Vice President and Head of US Oncology, Bristol Myers Squibb
Underwriter Session
Allie Brumel
Founder, The Breasties and Survivor
Courtney Burnett
Internist, HealthPartners, Author of Difficult Gifts, Survivor, and Patient Advocate
Benjamin Creelan
Thoracic Oncologist, H. Lee Moffitt Cancer Center
John Donvan
Contributor, AtlanticLIVE
Martin Edelman
Chair, Lung Cancer Foundation of America’s Scientific Advisory Board
Amanda R. Ferrero
Survivor and Patient Advocate
Andrea Ferris
President and CEO, LUNGevity Foundation
Underwriter Session
Elizabeth Fox
Senior Vice President, Clinical Trials Research, St. Jude Children’s Research Hospital
Ginger Gardner
Vice Chair, Hospital Operations, Department of Surgery at Memorial Sloan Kettering Cancer Center and Chair, Foundation for Women’s Cancer
Patricia J. Goldsmith
CEO, CancerCare
Underwriter Session
James Hamblin
Contributor, The Atlantic
Garret Hampton
President, Clinical Next Generation Sequencing Division, Thermo Fisher Scientific
Underwriter Session
Karen Knudsen
President and CEO, The American Cancer Society (ACS) and The American Cancer Society Action Network (ACS CAN)
Christopher S. Lathan
Chief Clinical Access and Equity Officer, Associate Medical Director, Dana-Farber Cancer Institute Network
Vincent Laudone
Chief of Surgery, Josie Robertson Surgery Center, Memorial Sloan Kettering Cancer Center
Jeanne Meserve
Contributor, AtlanticLIVE
Marleen Meyers
Director of Cancer Survivorship, Perlmutter Cancer Center, NYU Langone
Candace Montgomery
Senior Vice President and General Manager, AtlanticLIVE
Amanda Mull
Staff Writer, The Atlantic
Jill O’Donnell-Tormey
CEO and Director of Scientific Affairs, Cancer Research Institute
Solange Peters
Centre Hospitalier Universitaire Vaudois (CHUV) Oncology Department, Lausanne, President of the European Society of Medical Oncology
Underwriter Session
Alyx Porter
Neurologist, Mayo Clinic and Author, Navigating Life with a Brain Tumor
Al Roker
Weather and Feature Anchor, Today, and Co-host, Third Hour of Today
Nina Shah
Professor of Clinical Medicine, Division of Hematology-Oncology, University of California San Francisco
Underwriter Session
Padmanee Sharma
Professor, Genitourinary Medical Oncology and Immunology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
Underwriter Session
Ned Sharpless
Director, National Cancer Institute
Jonathan W. Simons
Prostate Cancer Foundation Board of Directors, Medical Director and Chief Science Officer, Marcus Foundation
Luke Timmerman
Founder and Editor, Timmerman Report
Underwriter Session
Hayley Romer
Publisher and Chief Revenue Officer, The Atlantic
Underwriter Session
Andy Schmeltz
Global President and General Manager, Pfizer Oncology
Underwriter Session
Fyodor Urnov
Professor, Molecular and Cell Biology Department, UC Berkeley and Scientific Director, Technology and Translation, Innovative Genomics Institute
Underwriter Session
Christine Ward
Vice President, Precision and Translational Medicine, Oncology Cell Therapy Therapeutic Area Unit, Takeda Oncology
Underwriter Session
Tony Wood
SVP Medicinal Science and Technology, GSK
Underwriter Session
Sarah Zhang
Staff Writer, The Atlantic
Subscribe to The Atlantic
Unlock unlimited access to The Atlantic, including exclusive events for subscribers. Join us today and help ensure a bright future for independent journalism.
SubscribeAgenda
Welcome
The War on Cancer, Revisited
Speakers
Karen Knudsen
President and CEO, The American Cancer Society (ACS) and The American Cancer Society Action Network (ACS CAN)
Ned Sharpless
Director, National Cancer Institute
Sarah Zhang
Staff Writer, The Atlantic
Pfizer Presents: Bringing the Power of Collaboration to Health-care Delivery
Summary
Produced by Pfizer and not The Atlantic’s editorial team.
Speakers
Hayley Romer*
Publisher and Chief Revenue Officer, The Atlantic
Andy Schmeltz*
Global President and General Manager, Pfizer Oncology
The Frontlines of Research
Speakers
Vinod Balachandran
Surgeon-Scientist, Memorial Sloan Kettering Cancer Center
John Donvan
Contributor, AtlanticLIVE
Jill O’Donnell-Tormey
CEO and Director of Scientific Affairs, Cancer Research Institute
GSK Presents: How Clues in our DNA are Uncovering New Opportunities to Advance Cancer Research
Summary
Produced by GSK and not The Atlantic’s editorial team.
Speakers
Fyodor Urnov*
Professor, Molecular and Cell Biology Department, UC Berkeley and Scientific Director, Technology and Translation, Innovative Genomics Institute
Tony Wood*
SVP Medicinal Science and Technology, GSK
Screenings for All
Speakers
Ginger Gardner
Vice Chair, Hospital Operations, Department of Surgery at Memorial Sloan Kettering Cancer Center and Chair, Foundation for Women’s Cancer
Christopher S. Lathan
Chief Clinical Access and Equity Officer, Associate Medical Director, Dana-Farber Cancer Institute Network
Jeanne Meserve
Contributor, AtlanticLIVE
Breakout Session - Bristol Myers Squibb Presents: The Future of Cancer Care: Transformative Innovation for All
Summary
Produced by Bristol Myers Squibb and not The Atlantic’s editorial team.
Speakers
Wendy Short Bartie*
Senior Vice President and Head of US Oncology, Bristol Myers Squibb
Patricia J. Goldsmith*
CEO, CancerCare
Nina Shah*
Professor of Clinical Medicine, Division of Hematology-Oncology, University of California San Francisco
Padmanee Sharma*
Professor, Genitourinary Medical Oncology and Immunology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
Eliminating Prostate Cancer
Speakers
James Hamblin
Contributor, The Atlantic
Vincent Laudone
Chief of Surgery, Josie Robertson Surgery Center, Memorial Sloan Kettering Cancer Center
Al Roker
Weather and Feature Anchor, Today, and Co-host, Third Hour of Today
Jonathan W. Simons
Prostate Cancer Foundation Board of Directors, Medical Director and Chief Science Officer, Marcus Foundation
A session produced by Astrazeneca
Summary
Produced by Astrazeneca and not The Atlantic’s editorial team.
Why There’s No Cure for Brain Cancer, Yet
Speakers
Courtney Burnett
Internist, HealthPartners, Author of Difficult Gifts, Survivor, and Patient Advocate
John Donvan
Contributor, AtlanticLIVE
Alyx Porter
Neurologist, Mayo Clinic and Author, Navigating Life with a Brain Tumor
Breakout Session - GSK Presents: Exploring the Future of Immuno-Oncology (IO)
Summary
Produced by GSK and not The Atlantic’s editorial team.
Speakers
Hesham Abdullah*
Senior Vice President and Head of Oncology Clinical Development, GSK
Andrea Ferris*
President and CEO, LUNGevity Foundation
Solange Peters*
Centre Hospitalier Universitaire Vaudois (CHUV) Oncology Department, Lausanne, President of the European Society of Medical Oncology
Luke Timmerman*
Founder and Editor, Timmerman Report
The Youngest Patients
Speakers
Amanda R. Ferrero
Survivor and Patient Advocate
Elizabeth Fox
Senior Vice President, Clinical Trials Research, St. Jude Children’s Research Hospital
Amanda Mull
Staff Writer, The Atlantic
New Innovations and the Future of Lung Cancer Care
Speakers
Benjamin Creelan
Thoracic Oncologist, H. Lee Moffitt Cancer Center
Martin Edelman
Chair, Lung Cancer Foundation of America’s Scientific Advisory Board
Jeanne Meserve
Contributor, AtlanticLIVE
Takeda Presents: The Future of Oncology: Precision Medicine and Comprehensive Diagnostic Testing
Summary
Produced by Takeda and not The Atlantic’s editorial team.
Speakers
Jeff Allen*
CEO and President, Friends of Cancer Research
Garret Hampton*
President, Clinical Next Generation Sequencing Division, Thermo Fisher Scientific
Christine Ward*
Vice President, Precision and Translational Medicine, Oncology Cell Therapy Therapeutic Area Unit, Takeda Oncology
Finding Hope
Speakers
Allie Brumel
Founder, The Breasties and Survivor
Jeanne Meserve
Contributor, AtlanticLIVE
Marleen Meyers
Director of Cancer Survivorship, Perlmutter Cancer Center, NYU Langone
Closing Remarks
Speakers
Jeanne Meserve
Contributor, AtlanticLIVE
underwriters
Founding
Presenting
Event Details
Virtual Event
Tuesday, November 16, 2021
11:00 am EDT
